Cipla share price slides after USFDA flags Pharmathen: what the Form 483 says
Shares of Cipla were down 4.6% at 1,460.2 rupees by midday on Wednesday after the U.S. Food and Drug Administration published inspection observations for Pharmathen International S.A., a contract manufacturer linked to the Indian drugmaker’s U.S. supply chain. The Economic Times
